SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Innovent Says China’s NMPA Accepts Sintilimab Application for Advanced Melanoma

Innovent said China’s National Medical Products Administration accepted a new indication application for sintilimab to treat advanced melanoma.

Related stories